Found: 4
Select item for more details and to access through your institution.
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 949, doi. 10.1007/s10555-021-09976-0
- By:
- Publication type:
- Article
It is not just the drugs that matter: the nocebo effect.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 1/2, p. 315, doi. 10.1007/s10555-019-09800-w
- By:
- Publication type:
- Article
Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 5, p. 663, doi. 10.3390/biom11050663
- By:
- Publication type:
- Article
Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1144, doi. 10.3390/cancers12051144
- By:
- Publication type:
- Article